Search

Your search keyword '"McGuinness, D"' showing total 350 results

Search Constraints

Start Over You searched for: Author "McGuinness, D" Remove constraint Author: "McGuinness, D"
350 results on '"McGuinness, D"'

Search Results

1. A Semantic Framework for Enabling Radio Spectrum Policy Management and Evaluation

5. Role of accelerated aging in limb muscle wasting of patients with COPD

7. Food Knowledge Graphs

8. Food ontologies

10. System Design and Implementation of the Detector Assembly of the Astro-H Soft X-Ray Spectrometer

11. The Design, Implementation, and Performance of the Astro-H SXS Aperture Assembly and Blocking Filters

14. 1467P POLO: Long-term safety and tolerability of olaparib for patients with a germline BRCA mutation and metastatic pancreatic cancer

15. 1468P POLO: Subsequent therapy after maintenance olaparib in patients with a germline BRCA mutation and metastatic pancreatic cancer

16. Geographic and Ethnic Heterogeneity of Germline BRCA1 or BRCA2 Mutation Prevalence Among Patients With Metastatic Pancreatic Cancer Screened for Entry Into the POLO Trial

20. 1527P Assessing clinical benefit of olaparib maintenance treatment in subgroups of patients with germline BRCA mutation (gBRCAm) and metastatic pancreatic cancer: Phase III POLO trial

21. Health-related quality of life in patients with a germline BRCA mutation and metastatic pancreatic cancer receiving maintenance olaparib

22. SO-3 Maintenance olaparib in patients aged ≥65 years with a germline BRCA mutation and metastatic pancreatic cancer: phase III POLO trial

28. Olaparib as maintenance treatment following first-line platinum-based chemotherapy (PBC) in patients (pts) with a germline BRCA mutation and metastatic pancreatic cancer (mPC): Phase III POLO trial

29. POLO: Health-related quality of life (HRQoL) of olaparib maintenance treatment versus placebo in patients with a germline BRCA mutation and metastatic pancreatic cancer (mPC)

30. POLO: Time to treatment discontinuation and subsequent therapies following maintenance olaparib for patients (pts) with a germline BRCA mutation and metastatic pancreatic cancer (mPC)

31. Olaparib as maintenance treatment following first-line platinum-based chemotherapy in patients with a germline BRCA mutation and metastatic pancreatic cancer: phase III POLO trial

32. Geological Methods

33. LATCHON: A MULTI-CENTRE, RANDOMISED CONTROLLED TRIAL OF PERINATAL SUPPORT TO IMPROVE BREASTFEEDING OUTCOMES IN WOMEN WITH OVERWEIGHT AND OBESITY

34. Maintenance olaparib for germline BRCA-mutated metastatic pancreatic cancer

35. Seq2RDF: An end-to-end application for deriving Triples from Natural Language Text

39. Is the grass always greener? Making sense of convergence and divergence in regeneration policies in England and Scotland

40. Caregiver burden and distress following the patient's discharge from psychiatric hospital

41. 126O - Olaparib as maintenance treatment following first-line platinum-based chemotherapy (PBC) in patients (pts) with a germline BRCA mutation and metastatic pancreatic cancer (mPC): Phase III POLO trial

42. 693P - POLO: Time to treatment discontinuation and subsequent therapies following maintenance olaparib for patients (pts) with a germline BRCA mutation and metastatic pancreatic cancer (mPC)

43. 675PD - POLO: Health-related quality of life (HRQoL) of olaparib maintenance treatment versus placebo in patients with a germline BRCA mutation and metastatic pancreatic cancer (mPC)

45. Sirtuins, Bioageing, and Cancer

50. m6a RNA methylation: the implications for health and disease

Catalog

Books, media, physical & digital resources